National News
NAFDAC halts Artemether/Lumefantrine registration
The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
World News13 hours agoICC convicts Sudanese militia Ali Kushayb for 20 Years
-
News12 hours agoJUST IN: ECOWAS declares regional state of emergency amid escalating security threats
-
National News12 hours agoBREAKING: Tinubu seeks Senate approval for troop deployment to Benin Republic
-
Metro2 days agoPanic in Anambra as gunmen kill several in market attack
-
News2 days agoImo govt seals hotel, mortuary linked to kidnapping, organ harvesting
-
News1 day agoTraditional leadership tougher than governing a state – Olubadan
-
News1 day agoNiger Gov receives 100 freed pupils after two weeks in captivity
-
News16 hours agoSahel alliance blasts Nigeria as NAF Plane makes emergency landing in Burkina Faso


